Arkolith/Insider Trading/ADGI/Form 4

Redmile Group, LLC

10% OwnerAdagio Therapeutics, Inc. (ADGI) · full profile →Form 4 · filed Aug 12, 2021
Net Buying
Open-Market Buys
$25.0M
Open-Market Sells
$0
Net Open-Market Flow
$25.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2021Conversion(C)1.9M——1.9M
Aug 10, 2021Buy(P)1.5M$17.00$25.0M3.4M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 10, 2021Conversion(C)1.9M—$00

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-104447) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML